All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-3869
Requests that the FDA include additional warnings that should be added to prescribing information on Hormonally-active contraceptives (HCs) and the development of autoimmune diseases
Documents
144
Comments
0
Description
Open
Key Dates
Comment Period OpensApr 14, 2026
Documents
| Type | Title | Status |
|---|---|---|
Supporting Material |
Keywords
CDER
Citizen Petition
Contraceptive Study Group
Requests that the FDA include additional
warnings that should be added to
prescribing information on
Hormonally-active contraceptives (HCs) and
the development of autoimmune diseases:
Data from Regulations.gov